Radiopharmaceutical Treatment of Malignant Pheochromocytoma

Apart from relieving effects of secreted catecholamines, treatments of malignant pheochromocytoma have achieved little success. When the radiopharmaceutical, meta-[131I] iodobenzylguanidine (I-131 MIBG ), was found to concentrate in some malignant pheochromocytomas, we calculated that this agent cou...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Journal of nuclear medicine (1978) 1984-02, Vol.25 (2), p.197
Hauptverfasser:	Sisson, James C, Shapiro, Brahm, Beierwaltes, William H, Glowniak, Jerry V, Nakajo, Masayuki, Mangner, Thomas J, Carey, James E, Swanson, Dennis P, Copp, Jean E, Satterlee, Winston G, Wieland, Donald M
Format:	Artikel
Sprache:	eng
Schlagworte:	3-Iodobenzylguanidine Adolescent Adrenal Gland Neoplasms - diagnostic imaging Adrenal Gland Neoplasms - radiotherapy Adult Aged Drug Evaluation Female Humans Iodine Radioisotopes - administration & dosage Iodine Radioisotopes - adverse effects Iodobenzenes - administration & dosage Iodobenzenes - adverse effects Male Middle Aged Neoplasm Metastasis Pheochromocytoma - diagnostic imaging Pheochromocytoma - radiotherapy Radionuclide Imaging Radiotherapy Dosage Time Factors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!